image of women in hospital bed being comforted by another

Many Lymphoma Patients Missing Out on Best Care

Study shows survival drops when CAR T therapy is not offered to eligible patients

Ciara Freeman, MD, PhD, specializes in treating people with multiple myeloma, a blood cancer that starts in plasma cells in the bone marrow.

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions

graphic of cancer cell being attacked by immune cells

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Moffitt extends its reach each year through the Business of Biotech conference, which attracts over 400 biotech executives, entrepreneurs, venture capitalists, angel investors and researchers to meet and collaborate on innovations.

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships

Moffitt leaders and researchers met with senators and representatives in the nation’s capital. It was a chance to highlight the importance of the federal government’s ongoing support to sustaining its mission.

Moffitt Cancer Center Leaders Highlight Importance of Cancer Research in D.C.

Ongoing cancer research funding is essential to Moffitt’s mission

Dallas Carroll was diagnosed with metastatic HER2-positive breast cancer a week after giving birth. A new immunotherapy treatment has given her hope. From left: Dallas’ stepdaughter Riley, husband Jeremy, and sons Finnry and Dakota.

Dendritic Cell Vaccines Changing Landscape for Breast Cancer Treatment

Moffitt research shows promise in breakthrough immunotherapy treatment

Mihaela Druta, MD, was principal investigator on the clinical trial that led to Tecelra’s FDA approval in August 2024. Druta is one of a limited number of specialists who focus on treating patients with sarcoma, a rare type of cancer that develops in connective tissues.

Improving Outcomes for Patients With Synovial Sarcoma

Moffitt treats first patient in the world with FDA-approved Tecelra

photo of Jasmine Cherry with her brother

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

For U.S. News & World Report ranking: hero image featuring Moffitt physicians taking care of patients and Moffitt McKinley Hospital

Moffitt Cancer Center Is One of the Nation’s Best Cancer Hospitals

Top ranked cancer center in Florida and the Southeast, based on U.S. News & World Report

Endeavor

Cambiar el idioma